News
A new application of the HTA Core Model – the HTA Core Model for Rapid Relative Effectiveness Assessment of pharmaceuticals
The HTA Core Model defines the content elements to be considered in a health technology assessment (HTA) and facilitates standardised reporting. The aim is to
National report based on pilot assessment of a vaccine using the HTA Core Model® published
LBI, (Ludwig Boltzmann Institute for Health Technology Assessment) Austria, has published a national report based on a EUnetHTA pilot rapid assessment of the herpes zoster
EUnetHTA Joint Position to EMA Public consultation on draft policy on the publication and access to clinical trial data
This document is the completed consultation form submitted 30 September, 2013 as the EUnetHTA Joint Position response to the public consultation on the EMA draft
WP7 SG1 Concept paper on Osteoarthritis
This document is WP7’s concept paper on osteoarthritis titled the “EunetHTA guideline on data requirements for the assessment of health technologies used for the treatment of
HTA Core Model Terms of Use Version 1.1
This new version of the terms of use contains key principles relevant to HTA Core Model users. Version 1.1 replaces the first version produced in
Public consultation response to WP5 Strand B’s draft project plan
Public Consultation replies_from_authors_for publication.pdf
1st pilot rapid assessment of WP5 JA2 Strand B on “Duodenal-jejunal bypass sleeve for the treatment of obesity with or without Type II Diabetes Mellitus”
The purpose of the assessment is to examine the effectiveness and safety of the duodenal-jejunal bypass sleeve/EndoBarrier® in in adults aged 18 years or older
The first pilot rapid assessment on ‘Zostavax for the prevention herpes zoster’
The purpose of the assessment is to evaluate Zostavax® for the prevention of herpes zoster. Final version of the assessment was published in September 2013
EUnetHTA-EMA f-t-f meeting summary 20121120, Copenhagen Denmark
Please find below the summary of the EUnetHTA / EMA face-to-face meeting, 20 November, 2012, Copenhagen, Denmark Follow this link to find all presentations from the meeting EUnetHTA-EMA
Joint EUnetHTA-EMA press release
European Medicines Agency and EUnetHTA reviewed the cooperation at our sixth meeting, 14 May 2013, London UK. The focus was on facilitation of development plans through advice
